𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats

✍ Scribed by M. Matsushita; M. Masaki; Y. Yagi; T. Tanaka; K. Wakitani

Publisher
SP Birkhäuser Verlag Basel
Year
1997
Tongue
English
Weight
224 KB
Volume
46
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JTE-522, a selective cyclooxygenase-2 in
JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats
✍ Min Wei; Keiichirou Morimura; Hideki Wanibuchi; Jun Shen; Elsayed I. Salim; Masa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB

## Abstract We have previously demonstrated that JTE‐522, a selective cyclooxygenase‐2 (COX‐2) inhibitor, inhibited development of aberrant crypt foci (ACF) in rats, a putative preneoplastic lesion in colon, and suggested its inhibitory potential in rat colon carcinogenesis. To evaluate the chemopr

JTE-522, a selective COX-2 inhibitor, in
JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: A vascular cast model study
✍ Hirotoshi Kobayashi; Tsuyoshi Gonda; Hiroyuki Uetake; Tetsuro Higuchi; Masayuki 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 506 KB

## Abstract The lung is a frequent site of metastasis from colorectal cancer, but angiogenesis of lung metastases has not been clarified. Some COX‐2 inhibitors prevent tumor growth, although the inhibitory mechanism at the metastatic site is obscure. We investigated the microvascular structure of s